Showing 2361-2370 of 23151 results for "".
The Plight of the Investigator
https://reachmd.com/programs/gi-insights/the-plight-of-the-investigator/4057/Are there fewer physician-scientists today than there were a few decades ago? What does the future landscape look like for medical research? Dr. Mark Donowitz, LeBoff Professor of Medicine and director of the Center for Epithelial Disorders at the Johns Hopkins University School of Medicine, as wellDifferentiating Agents in the Expanding HER2-Targeted Arsenal for Metastatic Breast Cancer
https://reachmd.com/programs/cme/differentiating-agents-in-the-expanding-her2-targeted-arsenal-for-metastatic-breast-cancer/29944/What’s the latest on managing HER2-expressing MBC with brain metastasis? Join our experts and learn about the most recent treatment strategies.Valbenazine and Patient-Centered Outcomes in TD: Insights From the KINECT-PRO Study
https://reachmd.com/clinical-practice/psychiatry-and-mental-health/valbenazine-and-patient-centered-outcomes-in-td-insights-from-the-kinect-pro-study/36175/Valbenazine and Patient-Centered Outcomes in TD: Insights From the KINECT-PRO StudyAddressing Unmet Needs in ATTR-CM Care: Key Considerations for Optimal Management
https://reachmd.com/programs/heart-matters/addressing-unmet-needs-in-attr-cm-care-key-considerations-for-optimal-management/33060/Explore challenges in diagnosing and treating transthyretin cardiac amyloidosis and how we can address them.No improvements in CV outcomes at 90 days with human ApoA-1 infusions post-MI
https://reachmd.com/programs/acc-action-center/no-improvements-in-cv-outcomes-at-90-days-with-human-apoa-1-infusions-post-mi/24288/ACC.24 - Michael Gibson shares the results of the AEGIS-II trial, in which infusions of human ApoA-1 - the building block of HDL-c - with CSL112 in the first month after an MI did not improve CV mortality, MI or stroke at 90 days.Research Identifies a Potential Link Between Sleep Apnea and Memory Loss
https://reachmd.com/programs/neurofrontiers/research-identifies-a-potential-link-between-sleep-apnea-and-memory-loss/24092/Does sleep apnea cause cognitive decline? A preliminary study shows potential link.Therapies & Vaccines on the Horizon for COVID-19
https://reachmd.com/programs/the-drug-report/therapies-vaccines-on-the-horizon-for-covid-19/11288/After much research activity has been devoted to finding a vaccine and cure for COVID-19, could there finally be hope amid this global pandemic?The Realities of Medicare Advantage: Perspectives on Physician & Patient Outcomes
https://reachmd.com/programs/perspectives-ama/the-realities-of-medicare-advantage-perspectives-on-physician-patient-outcomes/10790/What’s it really like to practice under Medicare Advantage plans? Hear two firsthand accounts of the opportunities and challenges.Detecting Depression: How to Assess Patients & the Benefits of TMS Treatment
https://reachmd.com/programs/primary-care-today/detecting-depression-how-to-assess-patients-and-benefits-of-tms-treatment/10131/When it comes to treating depression, should you turn to an alternate avenue? Dr. Brian McDonough and Dr. Paul Gross weigh in on the issue.Why Patients Delay Seeking an Early Diagnosis for Alzheimer’s Disease
https://reachmd.com/programs/alzheimers-disease-towards-early-detection/why-patients-delay-seeking-early-diagnosis-alzheimers-disease/8328/Dr. Matt Birnholz reports on a study revealing patient delays for seeking a diagnosis for dementia by at least a year.